‌

US Patent 7608594 Novobiocin analogues as anticancer agents

Patent 7608594 was granted and assigned to University of Kansas on October, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Current Assignee

University of Kansas

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Brian S. Blagg0

Len Neckers0

Xiao Ming Yu0

Date of Patent

October 27, 2009

0

Patent Application Number

112661490

Date Filed

November 3, 2005

0

Patent Citations Received

US Patent 12024536 C-terminal HSP90 inhibitors

0

US Patent 11708319 Biphenyl amides with modified ether groups as HSP90 inhibitors and HSP70 inducers

0

US Patent 11939333 Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same

0

US Patent 11944631 Combination therapies

0

Patent Primary Examiner

Patrick T. Lewis

0

Patent abstract

Novel analogues and derivatives of novobiocin are provided, including compounds having modifications to the amide side chain, coumarin ring, and sugar moieties. The compounds of the present invention are useful as heat shock protein 90 inhibitors, and may be used as anticancer and neuroprotective agents.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7608594 Novobiocin analogues as anticancer agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.